Key result
The H9C2 rat embryonic cardiomyocyte cell line was found to be a reliable in vitro model for doxorubicin cytotoxicity only for the first five passages, as further passaging led to altered morphology and lack of reproducibility.
Why the study?
Does the number of passages of H9C2 rat cardiomyocytes affect the repeatability of cytotoxicity study results?
Does the number of passages of H9C2 rat cardiomyocytes affect the repeatability of cytotoxicity study results?
The H9C2 rat cardiomyocyte cell line is a reliable in vitro model for cytotoxicity studies only for the first five passages, as further passaging alters cell morphology and increases sensitivity to toxic effects.
Answers are grounded in this paper and cite their sources.
H9C2 cells lose reliability after five passages in toxicity assays; leaves open need for standardized protocols and primary cell validation.
The embryonic cardiomyocyte cell line H9C2 is commonly used in numerous in vitro studies, including cardiotoxicity analyses of new drugs. So far no results were published for studies on cell parameters variability during the cell line ageing process. For this reason the aim of the study was to evaluate the effect of a number of H9C2 rat embryonic cardiomyocytes passages on repeatability of study results for selected cytotoxicity parameters, with doxorubicin as a model toxic agent. The cultures were passaged twenty-five times. Cells from passage 1, 5, 10, 15, 20 and 25 were treated with doxorubicin for 24 h. Then drug cytotoxicity was evaluated with the MTT test and additionally the nuclear factor erythroid 2-related factor (Nrf2) gene expression was examined. The analysis of oxidative stress intensity and cell morphology was also assessed. The microscopic appearance of cells indicates that untreated cardiomyocytes morphology changes as well as sensitivity to toxic effects increases with the number of passages. Also an increase in oxidative stress in cells occurs with further passaging of cardiomyocytes. Statistical significance of differences in conducted tests results depended on doxorubicin concentration but in many cases the H9C2 line was found to be a reliable in vitro model only for the first five passages. For this reason it is important to take into consideration that further culturing of cardiomyocytes may not ensure repeatability of study results due to the culture ageing.
No takes yet. Share an insight, caveat, or question.
Witek et al. (2016) studied In vitro cardiotoxicity model. Passage number and Doxorubicin vs. Early passages (passage 1) and untreated controls was evaluated on Cytotoxicity (MTT test), Nrf2 gene expression, oxidative stress, and cell morphology. The H9C2 rat embryonic cardiomyocyte cell line was found to be a reliable in vitro model for doxorubicin cytotoxicity only for the first five passages, as further passaging led to altered morphology and lack of reproducibility.
Synapse has enriched 10 related papers. Consider them for comparative context: